{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20040914",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4171",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21042s028,21052s021ltr.pdf",
              "date": "20040916",
              "type": "Letter"
            },
            {
              "id": "21397",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021052_S021_VIOXX.pdf",
              "date": "20080731",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4167",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20040630",
              "type": "Letter"
            },
            {
              "id": "41909",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20040630",
              "type": "Review"
            },
            {
              "id": "14250",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20040630",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20030519",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41910",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s017_021052_s011_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4166",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "41908",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "14249",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "4165",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "14248",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            },
            {
              "id": "21391",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "19990520",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "35982",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_52_vioxx_prntlbl.pdf",
              "date": "19990520",
              "type": "Label"
            },
            {
              "id": "41907",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_52_Vioxx.html",
              "date": "19990520",
              "type": "Review"
            },
            {
              "id": "23620",
              "url": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103420.htm",
              "date": "20040930",
              "type": "Other Important Information from FDA"
            },
            {
              "id": "26594",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/021042_52_vioxx_appltr.pdf",
              "date": "19990520",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20000302",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "24",
          "submission_status": "AP",
          "submission_status_date": "20160509",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "4172",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021042Orig1s033,021052Orig1s024ltr.pdf",
              "date": "20160511",
              "type": "Letter"
            },
            {
              "id": "14252",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021042s033,021052s024lbl.pdf",
              "date": "20160511",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "16",
          "submission_status": "AP",
          "submission_status_date": "20030627",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41912",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "4170",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf",
              "date": "20030706",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "14",
          "submission_status": "AP",
          "submission_status_date": "20030627",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21396",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "26598",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf",
              "date": "20030706",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "14251",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20040630",
              "type": "Label"
            },
            {
              "id": "21394",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20040630",
              "type": "Review"
            },
            {
              "id": "26597",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20040630",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20030806",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "35985",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21042se8-018,21052se8-012_vioxx_lbl.pdf",
              "date": "20030815",
              "type": "Label"
            },
            {
              "id": "4168",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21042se8-018,21052se8-012ltr.pdf",
              "date": "20030815",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "UNKNOWN",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "35984",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            },
            {
              "id": "21393",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "26596",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20020625",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "21395",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021052_S010_VIOXX.pdf",
              "date": "20080801",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20020411",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "21392",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-042s007_Vioxx.html",
              "date": "20020411",
              "type": "Review"
            },
            {
              "id": "26595",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21042s7s8s10s12s13s14ltr.pdf",
              "date": "20020411",
              "type": "Letter"
            },
            {
              "id": "35983",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21042s7lbl.pdf",
              "date": "20020411",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20000317",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "19991028",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "19",
          "submission_status": "AP",
          "submission_status_date": "20040819",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "41914",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021052_S019_VIOXX.pdf",
              "date": "20080731",
              "type": "Review"
            },
            {
              "id": "26600",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21052s019,026ltr.pdf",
              "date": "20040825",
              "type": "Letter"
            },
            {
              "id": "35986",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021052s026_021042s019lbl.pdf",
              "date": "20040819",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20031216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41913",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s024_021052_s017_VioxxtmTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "26599",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr017,21042slr024ltr.pdf",
              "date": "20031219",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "15",
          "submission_status": "AP",
          "submission_status_date": "20030627",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "41911",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021042_s020s021s022_021052_s014s015s016_VioxxTOC.html",
              "date": "20060601",
              "type": "Review"
            },
            {
              "id": "4169",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21052slr014,015,016,21042slr020,021,022ltr.pdf",
              "date": "20030706",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA021052",
      "sponsor_name": "MERCK",
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "VIOXX",
          "active_ingredients": [
            {
              "name": "ROFECOXIB",
              "strength": "25MG/5ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SUSPENSION",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "VIOXX",
          "active_ingredients": [
            {
              "name": "ROFECOXIB",
              "strength": "12.5MG/5ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SUSPENSION",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}